Hodgkin's Lymphoma Patients Who Underwent an Allogeneic Stem Cell Transplantation
Conditions
Brief summary
Relapsed and refractory Hodgkin's lymphoma (HL) patients may experience long-term survival after allogeneic transplant (alloSCT), but disease recurrence represents the main cause of treatment failure. PET (positron-emission tomography) -positive patients after alloSCT have a dismal outcome. Serum TARC (thymus and activation-regulated chemokine) is produced by Reed-Sternberg cells and may be a marker of disease. Our study was aimed at assessing whether TARC levels after alloSCT were correlated to disease status and whether TARC monitoring could increase the ability to predict relapse.
Interventions
OTHERno treatment
Sponsors
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Study design
Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hodgkin's lymphoma patients who underwent an alloSCT at Fondazione IRCCS Istituto Nazionale dei Tumori and who were monitored by PET and TARC before and after alloSCT from 2009
Exclusion criteria
* Hodgkin's lymphoma patients who underwent an alloSCT who were not monitored by PET or/and TARC
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Correlation between disease status and serum TARC level | One year after transplant | Serum TARC level was measured before alloSCT in Hodgkin's lymphoma patients and after alloSCT. The median time interval after alloSCT was 47 days. PFS was estimated at one year based on TARC value. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The correlation between TARC levels and PET results after alloSCT | Before alloSCT, monthly during the first 6 months after alloSCT and every 2 months until 2 years of follow-up, then at the time of clinical check-up (usually every 6 months) | We selected TARC values done on the days of PET to assess a cut-off value of TARC that was correlated to a positive or negative PET |
Countries
Italy
Outcome results
None listed